Details of the Drug
General Information of Drug (ID: DM09LY4)
Drug Name |
3,3-Dimethyl-dihydro-furan-2-one
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
3709-08-8; alpha,alpha-Dimethyl-gamma-butyrolactone; 3,3-dimethyldihydrofuran-2(3h)-one; 3,3-dimethyloxolan-2-one; 2(3H)-Furanone, dihydro-3,3-dimethyl-; Dihydro-3,3-dimethyl-2(3H)-furanone; 2,2-Dimethyl-4-butyrolactone; UPVAIJPDWVTFKT-UHFFFAOYSA-N; Butyric acid, 2,2-dimethyl-4-hydroxy-, g-lactone; Dimethylbutanolid; alpha-DMgBL; NSC1094; AC1L3STF; AC1Q6HQD; 2,2-dimethylbutyrolactone; Furanone, dihydrodimethyl-; a,a-Dimethyl- -butyrolactone; SCHEMBL149596; CHEMBL33962; CTK2A6366; DTXSID30190584; MolPort-009-198-442
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 114.14 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.1 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 0 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||